Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Shares Issued (2018 - 2025)

Health Catalyst (HCAT) has disclosed Shares Issued for 8 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 143.97% year-over-year to $1.5 million, compared with a TTM value of $1.9 million through Sep 2025, up 1067.69%, and an annual FY2024 reading of $2.4 million, up 153.79% over the prior year.
  • Shares Issued was $1.5 million for Q3 2025 at Health Catalyst, up from -$695000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $7.6 million in Q2 2021 and bottomed at -$12.5 million in Q4 2021.
  • Average Shares Issued over 5 years is $537111.1, with a median of $662500.0 recorded in 2024.
  • The sharpest move saw Shares Issued crashed 479.16% in 2023, then soared 3375.0% in 2025.
  • Year by year, Shares Issued stood at -$12.5 million in 2021, then soared by 104.78% to $595000.0 in 2022, then plummeted by 479.16% to -$2.3 million in 2023, then surged by 115.51% to $350000.0 in 2024, then surged by 339.14% to $1.5 million in 2025.
  • Business Quant data shows Shares Issued for HCAT at $1.5 million in Q3 2025, -$695000.0 in Q2 2025, and $695000.0 in Q1 2025.